Baudax Bio, Inc. (BXRX) Stock Analysis
DELISTED 2023
What happened to Baudax Bio, Inc. (BXRX) stock?
Baudax Bio, Inc. (BXRX) no longer trades on public markets. It was delisted in November 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- November 2023
- Last recorded price (historical):
- $0.0218 (last quote on record before the November 2023 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Baudax Bio, Inc. (BXRX). Baudax Bio, Inc. is a pharmaceutical company focused on developing and commercializing products for acute care settings. Their lead product, ANJESO, targets moderate to severe pain management.
Last analyzed: Mar 18, 2026Baudax Bio, Inc. (BXRX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy BXRX shares?
No. BXRX stopped trading on public markets in November 2023, so the shares are not available through a broker. Anything you see quoted for BXRX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before BXRX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Baudax Bio, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.